UNQUOTE

NETHERLANDS - LSP leads EUR 3m investment round in BMEYE

  • Wietske Blees
  • LinkedIn  
  • Google plus  

Life Science Partners has announced that it has led a EUR 3m Series A financing round of BMEYE, a Dutch medical device company. The round was led by LSP and included a group of Silicon Valley and Dutch groups TechFund and BAT (Business Angels Technostarters). BMEYE is the first life science investment of TechnoPartner, a Dutch agency supported by the Department of Economic Affairs that provided seed funds to LSP, TechFund and BAT. LSP also announced the appointment of René Kuijten as non-executive director representing LSP on the supervisory board of BMEYE.

BMEYE develops, markets and sells medical devices with broad application in clinic cardiology and cardiovascular monitoring. Specifically, BMEYE produces patient monitors that non-invasively measure continuous blood pressure and cardiac output. The company was established in April 2005 as a spin-out of TNO Biomedical Instrumentation (BMI) and is based in Amsterdam and in St. Louis, USA.
  • LinkedIn  
  • Google plus  

More on Early-stage

Latest News